These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6604003)

  • 1. Evaluation of a coagulation assay determining the activity state of factor VII in plasma.
    van Deijk WA; van Dam-Mieras MC; Muller AD; Hemker HC
    Haemostasis; 1983; 13(3):192-7. PubMed ID: 6604003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to measure factor VII and factor VII activation.
    Osterud B
    Haemostasis; 1983; 13(3):161-8. PubMed ID: 6350121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII.
    Muller AD; van Deijk WA; Devilée PP; van Dam-Mieras MC; Hemker HC
    Br J Haematol; 1986 Feb; 62(2):367-77. PubMed ID: 3484966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold-promoted activation of factor VII: is It a problem under blood bank conditions?
    Seligsohn U; Zivelin A; Bar-Shani S
    Haemostasis; 1983; 13(3):186-91. PubMed ID: 6604002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VII clotting assay: influence of different thromboplastins and factor VII-deficient plasmas. CISMEL Study Group.
    Poggio M; Tripodi A; Mariani G; Mannucci PM
    Thromb Haemost; 1991 Feb; 65(2):160-4. PubMed ID: 2053102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulation.
    Kitchen S; Malia RG; Greaves M; Preston FE
    Thromb Res; 1988 Apr; 50(1):191-200. PubMed ID: 3400081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
    Morrissey JH; Macik BG; Neuenschwander PF; Comp PC
    Blood; 1993 Feb; 81(3):734-44. PubMed ID: 8427965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions.
    Seligsohn U; Zivelin A; Zwang E; Bar-Shani S
    Transfusion; 1984; 24(2):171-2. PubMed ID: 6608809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for determination of the factor VII-phospholipid complex using Normotest.
    Dalaker K; Janson TL; Johnsen B; Skartlien AH; Prydz H
    Thromb Res; 1987 Aug; 47(3):287-93. PubMed ID: 3629556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease.
    Miller GJ; Walter SJ; Stirling Y; Thompson SG; Esnouf MP; Meade TW
    Br J Haematol; 1985 Feb; 59(2):249-58. PubMed ID: 3871629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
    Morrissey JH
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methodological studies on the immunologic determination of proconvertin (factor VII)].
    Frenzel J; Maak B; Sachse U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(3):357-70. PubMed ID: 52582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
    Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
    Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
    Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the initiation of coagulation by factor VII.
    Nemerson Y
    Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and comparison of immune-depleted and hereditary factor-VII-deficient plasmas as substrate plasmas for factor VII assays.
    Brandt JT; Triplett DA; Fair DS
    Am J Clin Pathol; 1986 May; 85(5):583-9. PubMed ID: 3518398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VII and haemostasis.
    Osterud B
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VII in an industrial population.
    Brozovic M; Stirling Y; Harricks C; North WR; Meade TW
    Br J Haematol; 1974 Nov; 28(3):381-91. PubMed ID: 4441467
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
    Gordon EM; Ratnoff OD; Jones PK
    J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.